65 related articles for article (PubMed ID: 18430791)
21. Clinical consequences of ADRbeta2 polymorphisms.
Hawkins GA; Weiss ST; Bleecker ER
Pharmacogenomics; 2008 Mar; 9(3):349-58. PubMed ID: 18303970
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of beta agonists.
Donohue JF
Respir Care; 2008 May; 53(5):618-22; discussion 623-4. PubMed ID: 18426615
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
24. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
25. [Polymorphism of beta 2-adrenergic receptors].
Weglarz L; Grzanka A; Kierot J; Wilczok T
Wiad Lek; 2003; 56(5-6):283-8. PubMed ID: 14526489
[TBL] [Abstract][Full Text] [Related]
26. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
27. Beta-2 adrenergic receptor genetic polymorphisms and asthma.
Hizawa N
J Clin Pharm Ther; 2009 Dec; 34(6):631-43. PubMed ID: 20175796
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
Chung LP; Waterer G; Thompson PJ
Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of β2-agonists.
Hizawa N
Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
[TBL] [Abstract][Full Text] [Related]
30. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Gordon E; Lazarus SC
J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of asthma.
Hawkins GA; Peters SP
Methods Mol Biol; 2008; 448():359-78. PubMed ID: 18370237
[TBL] [Abstract][Full Text] [Related]
32. beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.
Taylor DR
Expert Opin Pharmacother; 2007 Dec; 8(18):3195-203. PubMed ID: 18035963
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetic tests in asthma therapy.
Yu IW; Bukaveckas BL
Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
[TBL] [Abstract][Full Text] [Related]
34. Current options in the treatment of acute bronchospasm.
Berger WE
Postgrad Med; 2005 Dec; 118(6 Suppl Acute):18-26. PubMed ID: 19667712
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics of the beta 2-adrenergic receptor gene.
Ortega VE; Hawkins GA; Peters SP; Bleecker ER
Immunol Allergy Clin North Am; 2007 Nov; 27(4):665-84; vii. PubMed ID: 17996583
[TBL] [Abstract][Full Text] [Related]
36. [Practice guideline 'Medical treatment of COPD'].
Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of tiotropium in the prevention of exacerbations of COPD.
Anzueto A; Miravitlles M
Ther Adv Respir Dis; 2009 Jun; 3(3):103-11. PubMed ID: 19617284
[TBL] [Abstract][Full Text] [Related]
38. Three generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma: a review.
Jalba MS
J Asthma; 2008; 45(1):9-18. PubMed ID: 18259990
[TBL] [Abstract][Full Text] [Related]
39. The assessment and management of patients with acute asthma.
Behbehani N; Fitzgerald JM
Int J Tuberc Lung Dis; 2006 Apr; 10(4):356-64. PubMed ID: 16602397
[TBL] [Abstract][Full Text] [Related]
40. [Role of long-acting beta-agonists in the treatment of asthma].
Marti C; Janssens JP; Rutschmann O
Rev Med Suisse; 2008 Oct; 4(175):2203-4, 2206-7. PubMed ID: 19024574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
